Rationale for treatment durations of targeted cancer agents

Pearson, Sallie Anne, Chin, Melvin, Faedo, Margaret and Ward, Robyn (2010) Rationale for treatment durations of targeted cancer agents. Lancet Oncology, 11 12: 1113-1115. doi:10.1016/S1470-2045(10)70236-9


Author Pearson, Sallie Anne
Chin, Melvin
Faedo, Margaret
Ward, Robyn
Title Rationale for treatment durations of targeted cancer agents
Journal name Lancet Oncology   Check publisher's open access policy
ISSN 1470-2045
1474-5488
Publication date 2010-12-01
Year available 2010
Sub-type Editorial
DOI 10.1016/S1470-2045(10)70236-9
Volume 11
Issue 12
Start page 1113
End page 1115
Total pages 3
Place of publication London, United Kingdom
Publisher The Lancet Publishing Group
Language eng
Keyword Her2 Positive Breast Cancer
Adjuvant Chemotherapy
Trastuzumab
Trial
Docetaxel
Q-Index Code CX
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Editorial
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 2 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 2 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 11 Feb 2015, 20:01:39 EST by Ms Kate Rowe on behalf of School of Medicine